Hemsol-hc
Drug - Hemsol-hc
The trade name of the product as shown on the labeling.
Dosage -
CREAM; TOPICAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Hydrocortisone Acetate
Multiple ingredients are in alphabetical order.
Strength -
1%
The potency of the active ingredient(s), Hydrocortisone Acetate. May repeat for multiple part products.
Applicant -
ABLE
The firm name holding legal responsibility for Hemsol-hc. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
081274
The FDA assigned number to Hemsol-hc. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Hemsol-hc. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Jun 19, 1992
The date Hemsol-hc was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Hemsol-hc. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
DISCN
The group or category of approved drugs Hemsol-hc is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Able Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Hemsol-hc.
Hemsol-hc
|
